# Radiation Post-CAR T in Refractory Lymphoma

> **NCT04473937** · NA · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 3 (actual)

## Conditions studied

- Hematologic Malignancy
- Refractory Lymphoma

## Interventions

- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT04473937
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-01-05
- **Primary completion:** 2021-10-09
- **Final completion:** 2023-07-03
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Futility
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04473937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04473937, "Radiation Post-CAR T in Refractory Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04473937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*